Patients again noticed that antiepileptic drugs from the Dapkin line were missing from retail stores. There were already problems with them at the beginning of 2026, several doctors and patients told Kommersant.
France's Snoopy, which makes the product, says the problem is limited production capacity, which is periodically shut down due to environmental reviews.
However, there are at least 12 similar drugs on the Russian market.